Julian Baker’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-112,897
Closed -$13M 137
2020
Q4
$13M Sell
112,897
-25,848
-19% -$2.9M 0.05% 67
2020
Q3
$13.5M Sell
138,745
-46,300
-25% -$5.33M 0.05% 63
2020
Q2
$22.7M Sell
185,045
-185,800
-50% -$21.1M 0.1% 44
2020
Q1
$32.5M Hold
370,845
0.2% 35
2019
Q4
$38.8M Hold
370,845
0.21% 33
2019
Q3
$42.7M Hold
370,845
0.29% 27
2019
Q2
$63.9M Sell
370,845
-57,500
-13% -$9.95M 0.43% 21
2019
Q1
$72.2M Hold
428,345
0.46% 22
2018
Q4
$41.7M Buy
428,345
+31,645
+8% +$4.15M 0.34% 26
2018
Q3
$68.5M Buy
396,700
+74,900
+23% +$10.8M 0.45% 24
2018
Q2
$44.9M Buy
321,800
+100,000
+45% +$14.2M 0.34% 27
2018
Q1
$25M Hold
221,800
0.21% 40
2017
Q4
$29.3M Buy
221,800
+146,800
+196% +$17.2M 0.25% 37
2017
Q3
$7.61M Buy
+75,000
New +$8.03M 0.06% 63
2016
Q3
Sell
-15,000
Closed -$1.37M 138
2016
Q2
$1.37M Hold
15,000
0.01% 109
2016
Q1
$1.08M Buy
+15,000
New +$823K 0.01% 116
2014
Q1
Sell
-94,172
Closed -$3.91M 111
2013
Q4
$3.91M Buy
+94,172
New +$2.98M 0.06% 70

Other funds holding GWPH

Julian Baker's GWPH Position: Q1 2021 in Review

Julian Baker sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2021, closing a stake of 112,897 shares — an estimated $13M sold.

Julian Baker first reported a position in GWPH in Q4 2013 and held it in 17 quarters. The position peaked at $72.2M in Q1 2019. 297 funds tracked by Wall St. Rank hold GWPH as of Q1 2021.

  • Julian Baker reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2021 after selling out during the quarter.
  • Julian Baker sold 112,897 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2021, an estimated $13M.
  • Julian Baker first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2013 and held it in 17 quarters.
  • Julian Baker's GW Pharmaceuticals Plc American Depositary Shares position peaked at $72.2M in Q1 2019.
  • 297 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2021.

Based on Baker Bros. Advisors's 13F filing for Q1 2021, filed 17 May 2021.